Nutex Health Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
NUTX$186.25-4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)
| Common Stock · Additional Paid-inCapital · Retained Earnings (Accumulated Deficit) · NoncontrollingInterests · TotalEquity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (In thousands, except share data) · Shares · Amount | |||||||||||
| Balance at December 31, 2024 | 5,511,452 | $6 | $489,409 | $(356,976) | $56,094 | $188,533 | |||||
| Common stock issued for Employee Stock Purchase Plan | 1,161 | — | 40 | — | — | 40 | |||||
| Stock-based compensation | 422,091 | — | 23,252 | — | — | 23,252 | |||||
| Vesting of Restricted Stock Units | 15,835 | — | — | — | — | — | |||||
| Distributions | — | — | — | — | (7,364) | (7,364) | |||||
| Net income | — | — | — | 21,217 | 29,589 | 50,806 | |||||
| Balance at March 31, 2025 | 5,950,539 | $6 | $512,701 | $(335,759) | $78,319 | $255,267 | |||||
| Common stock issued for Employee Stock Purchase Plan | 866 | — | 65 | — | — | 65 | |||||
| Asset acquisition noncontrolling interest | — | — | — | — | 789 | 789 | |||||
| Debt conversion to common stock | 17,874 | — | 477 | — | — | 477 | |||||
| Stock-based compensation | 602,798 | 1 | 75,304 | — | — | 75,305 | |||||
| Vesting of Restricted Stock Units | 23,032 | — | — | — | — | — | |||||
| Contributions | — | — | 152 | — | 90 | 242 | |||||
| Distributions | — | — | — | — | (11,412) | (11,412) | |||||
| Net income | — | — | — | (17,697) | 33,841 | 16,144 | |||||
| Balance at June 30, 2025 | 6,595,109 | $7 | $588,699 | $(353,456) | $101,627 | $336,877 | |||||
| Balance at December 31, 2025 | 7,086,670 | $7 | $615,627 | $(286,187) | $93,990 | $423,437 | |||
|---|---|---|---|---|---|---|---|---|---|
| Common stock issued for Employee Stock Purchase Plan | 547 | — | 97 | — | — | 97 | |||
| Vesting of Restricted Stock Units | 52,096 | — | — | — | — | — | |||
| Stock-based compensation | 12,753 | — | 1,604 | — | — | 1,604 | |||
| Stock repurchases and retirements | (200,444) | — | (31,730) | — | — | (31,730) | |||
| Contributions | — | — | 68 | — | 1,171 | 1,239 | |||
| Distributions | — | — | — | — | (15,357) | (15,357) | |||
| Net income | — | — | — | 46,807 | 15,956 | 62,763 | |||
| Balance at March 31, 2026 | 6,951,622 | $7 | $585,666 | $(239,380) | $95,760 | $442,053 | |||
| Warrant exercises | 2,500 | — | 75 | — | — | 75 | |||
| Common stock issued for Employee Stock Purchase Plan | 1,962 | — | 197 | — | — | 197 | |||
| Stock-based compensation | — | — | 724 | — | — | 724 | |||
| Stock repurchases and retirements | (112,299) | — | (18,957) | — | — | (18,957) | |||
| Contributions | — | — | 142 | — | 24 | 166 | |||
| Distributions | — | — | — | — | (13,263) | (13,263) | |||
| Net income | — | — | — | 65,842 | 30,475 | 96,317 | |||
| Balance at June 30, 2026 | 6,843,785 | $7 | $567,847 | $(173,538) | $112,996 | $507,312 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.